Paragon Capital Management LTD P Lx Pharma Inc. Transaction History

Paragon Capital Management LTD

  • $553 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 19, 2022
SELL
$3.54 - $8.3 $354 - $830
-100 Closed
0 $0
Q4 2021

Jan 27, 2022
BUY
$7.69 - $19.66 $769 - $1,966
100 New
100 $1,000

Others Institutions Holding PLXP

# of Institutions
4
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Paragon Capital Management LTD Portfolio

Follow Paragon Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email